Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP316574.RAJx4x74io3iOi7fX_2s68YK7oZE7Ot0szYqtkQVpPWx0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP316574.RAJx4x74io3iOi7fX_2s68YK7oZE7Ot0szYqtkQVpPWx0130_assertion type Assertion NP316574.RAJx4x74io3iOi7fX_2s68YK7oZE7Ot0szYqtkQVpPWx0130_head.
- NP316574.RAJx4x74io3iOi7fX_2s68YK7oZE7Ot0szYqtkQVpPWx0130_assertion description "[Even more, molecular markers such as MLL partial tandem duplications (MLL-PTD) or FLT3 length mutations (FLT3-LM) were found to characterize specific subtypes of AML and completed the genetic marker profile.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP316574.RAJx4x74io3iOi7fX_2s68YK7oZE7Ot0szYqtkQVpPWx0130_provenance.
- NP316574.RAJx4x74io3iOi7fX_2s68YK7oZE7Ot0szYqtkQVpPWx0130_assertion evidence source_evidence_literature NP316574.RAJx4x74io3iOi7fX_2s68YK7oZE7Ot0szYqtkQVpPWx0130_provenance.
- NP316574.RAJx4x74io3iOi7fX_2s68YK7oZE7Ot0szYqtkQVpPWx0130_assertion SIO_000772 15124693 NP316574.RAJx4x74io3iOi7fX_2s68YK7oZE7Ot0szYqtkQVpPWx0130_provenance.
- NP316574.RAJx4x74io3iOi7fX_2s68YK7oZE7Ot0szYqtkQVpPWx0130_assertion wasDerivedFrom befree-20140225 NP316574.RAJx4x74io3iOi7fX_2s68YK7oZE7Ot0szYqtkQVpPWx0130_provenance.
- NP316574.RAJx4x74io3iOi7fX_2s68YK7oZE7Ot0szYqtkQVpPWx0130_assertion wasGeneratedBy ECO_0000203 NP316574.RAJx4x74io3iOi7fX_2s68YK7oZE7Ot0szYqtkQVpPWx0130_provenance.